Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
ChitogenX Inc
C.CHGX
Alternate Symbol(s):
CHNXF
Healthcare
Biotechnology
ChitogenX Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of orthopaedic and sports medicine surgeries in Canada. It develops Ortho-R, a biopolymer for rotator cuff repair; and Ortho-M, a biopolymer for meniscus repair. The company was formerly known as Ortho...
Regenerative Technologies Inc. and changed its name to ChitogenX Inc. in September 2022. ChitogenX Inc. was incorporated in 2015 and is headquartered in Kirkland, Canada.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (CSE:CHGX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(21)
•••
eric40
X
Comment by
eric40
on Aug 18, 2020 8:58pm
RE:RE:Positive Histology Results From Pivotal Preclinical study
And soon they will start the phase 1 clinical trial with placebo control. Within 24 months, results will be out and if result are as good as on the animal model, the market cap will jump 25 X
...more
(41)
•••
RockLobster1
X
Comment by
RockLobster1
on Jul 23, 2020 1:12pm
RE:Positive Histology Results From Pivotal Preclinical study
the positive results continue... and it seems more volume buying coming in, slowly but surely.
(41)
•••
RockLobster1
X
Post by
RockLobster1
on Jul 23, 2020 1:04pm
Positive Histology Results From Pivotal Preclinical study
Ortho Regenerative Technologies Releases New Positive Histology Results From Pivotal Preclinical GLP Rotator Cuff Tear Repair Efficacy Study in Large-Animal Model Thursday, July 23, 2020, 7:00 AM ET
...more
(41)
•••
RockLobster1
X
Post by
RockLobster1
on Jul 01, 2020 3:26pm
First Quarter 2021 Results
Ortho Regenerative Technologies Reports its First Quarter 2021 Results CNW Group June 30, 2020 Preclinical results confirm
...more
(41)
•••
RockLobster1
X
Post by
RockLobster1
on May 21, 2020 8:03pm
Licensing Agreement
Ortho Regenerative Technologies Enters Into Licensing Agreement to Expand the Scope of its Technological Platform Applications CNW Group May 20, 2020
...more
(1)
•••
SamGuterres33
X
Post by
SamGuterres33
on Dec 30, 2019 7:35am
Something on ORTH
Check it out https://cutt.ly/WrtXFvM
(41)
•••
RockLobster1
X
Comment by
RockLobster1
on Aug 28, 2019 9:51am
RE:Business Update on its Ortho-R Rotator Cuff Program
some of it formats better in the quote it seems... anyways looks like some progress,,,
(41)
•••
RockLobster1
X
Post by
RockLobster1
on Aug 28, 2019 9:50am
collaborative agreement with leading global Orthopaedic Comp
Agreement could lead to significant broadening of the Company's proprietary RESTORE platform and its therapeutic applications Ortho RTi" or the "Company"), an emerging
...more
(41)
•••
RockLobster1
X
Post by
RockLobster1
on Aug 14, 2019 12:24pm
Business Update on its Ortho-R Rotator Cuff Program
Ortho RTi" or the "Company"), an emerging Orthobiologics company, provided today a business update on its Ortho-R rotator cuff program." type="text"> MONTREAL, Aug.
...more
(41)
•••
RockLobster1
X
Comment by
RockLobster1
on Jul 23, 2019 7:49pm
RE:RE:New CEO - looks impressive
Just a retail investor with a few shares. Sorry spanky, I'm not able to give you full daily complete analysis of your investments, you'll have to look for someone else to hold your hand.
...more
(41)
•••
RockLobster1
X
Post by
RockLobster1
on Jun 17, 2019 10:27am
New CEO - looks impressive
Ortho Regenerative Technologies Announces Changes in Executive Leadership Monday, June 17, 2019, 8:00 AM ET Bio-Pharma veteran Claude LeDuc to replace Dr. Brent Norton as President and Chief
...more
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
New Gold Opportunities in the Cariboo Region (CSE:GCC) (OTC:GCCFF)
Sekur Private Data CEO Updates on Growth, Market Expansion, Corporate Developments and New Product Launch
Cielo Executes LOI to Advance Clean Fuels Project Development Through Strategic Asset Acquisition
A different approach to mineral exploration and development — scale, diversification & optionality
Podcasts